HomeREGULATORY
REGULATORY

JPMA Official Hails MHLW Discussions on Use of “Specified Clinical Research” Data in Application Dossiers
(Sep.10.2018)

(from left) Dr Fujiwara, Mr Hakuno, Mr Kunitada
A senior official of the Japan Pharmaceutical Manufacturers Association (JPMA) on September 7 welcomed news that the health ministry has started discussions on ways to harness data from so-called “specified clinical research (tokutei rinsho kenkyu)” for drug application dossiers ...
(LOG IN FOR FULL STORY)

News Calendar